CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | HOUGEN ELIZABETH L EVP, Finance & CFO | Grant or award | +4,140 | 95,030 | ||
| 2024-02-01 | Geary Richard S EVP, Chief Development Officer | Grant or award | +3,820 | 89,295 | ||
| 2024-02-01 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | Grant or award | +4,140 | 37,950 | ||
| 2024-02-01 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award | +3,609 | 80,932 | ||
| 2024-01-31 | Swayze Eric EVP Research | Sale 10b5-1 | −10,773 | $52.00 | $560K | 32,516 |
| 2024-01-25 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −2,285 | $51.75 | $118K | 151,851 |
| 2024-01-25 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −6,450 | $51.75 | $334K | 46,802 |
| 2024-01-17 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | Sale | −5,564 | $50.42 | $281K | 33,810 |
| 2024-01-17 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −7,744 | $50.42 | $390K | 53,252 |
| 2024-01-17 | Birchler Brian EVP, Corp and Development Ops | Sale | −4,497 | $50.42 | $227K | 44,582 |
| 2024-01-17 | Swayze Eric EVP Research | Sale | −6,296 | $50.42 | $317K | 43,289 |
| 2024-01-17 | Swayze Eric EVP Research | Sale | −9 | $50.42 | $454 | 85 |
| 2024-01-17 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale | −5,482 | $50.42 | $276K | 47,850 |
| 2024-01-17 | Monia Brett P Chief Executive Officer | Sale | −32,059 | $50.42 | $1.6M | 154,136 |
| 2024-01-17 | HOUGEN ELIZABETH L EVP, Finance & CFO | Sale | −8,683 | $50.42 | $438K | 90,890 |
| 2024-01-17 | Geary Richard S EVP, Chief Development Officer | Sale | −7,338 | $50.42 | $370K | 85,475 |
| 2024-01-17 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −6,745 | $50.42 | $340K | 77,323 |
| 2024-01-17 | Baroldi Joseph EVP, Chief Business Officer | Sale | −1,460 | $50.42 | $74K | 12,799 |
| 2024-01-17 | Baroldi Joseph EVP, Chief Business Officer | Sale | −564 | $50.42 | $28K | 1,640 |
| 2024-01-16 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | Exercise or conversion | +15,062 | 39,374 |
Page 41 of 44 · 873 trades